Pembrolizumab and Pemetrexed for Older Patients with Nonsquamous NSCLC and Programmed Cell Death-Ligand 1 Tumor Proportion Scores of Less Than 50%
JTO clinical and research reports(2024)
Key words
Pembrolizumab,Pemetrexed,Nonsquamous non-small cell lung cancer,Older patients,Programmed cell death 1
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined